investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
Michele S Redell
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
George P Studzinski
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
Leukaemia
Hematology and hematologic malignancies
Susan L Slager
Genetic Epidemiology Of Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Thomas J Kipps
Chronic Lymphocytic Leukemia Research Consortium
Leukaemia
Hematology and hematologic malignancies
Joseph L Wiemels
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status
Leukaemia
Hematology and hematologic malignancies
Karin L Gaensler
Efficacy and Safety of Novel CD80 IL15 IL15Ra Expressing Autologous AML Vaccines
Leukaemia
Hematology and hematologic malignancies
Effie W Petersdorf
Hematopoietic Stem Cell and Cord Blood Transplantation
Leukaemia
Hematology and hematologic malignancies
Ronald Hoffman
A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression
Leukaemia
Hematology and hematologic malignancies
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Hematology and hematologic malignancies
Stephanie J Lee
Improving Outcomes Assessment in Chronic Graft versus Host Disease
Leukaemia
Hematology and hematologic malignancies
